T0	Outcomes 155 163	efficacy
T1	Outcomes 483 491	Z scores
T2	Outcomes 580 635	bone alkaline phosphatase (B-ALP) and osteocalcin (OC).
T3	Outcomes 654 682	imbalance in bone remodeling
T4	Outcomes 690 711	high bone resorption.
T5	Outcomes 712 738	Bone mineral density (BMD)
T6	Outcomes 765 779	changes in BMD
T7	Outcomes 859 892	lumbar spine and the femoral neck
T8	Outcomes 908 969	Biochemical markers except urinary calcium and hydroxyproline
T9	Outcomes 1027 1059	BMD changes at the lumbar spine.
T10	Outcomes 1123 1149	positive spine BMD changes
T11	Outcomes 1198 1222	bone biochemical markers
T12	Outcomes 1327 1357	association of B-ALP and D-Pyr
T13	Outcomes 1396 1408	BMD variance
T14	Outcomes 1417 1457	association of B-ALP, PTH, and estradiol
T15	Outcomes 1501 1525	biochemical bone markers
T16	Outcomes 1550 1561	bone effect
T17	Outcomes 1568 1576	increase